Starcoin Group Limited (0399.HK)
HKSE · HKD · Consumer Cyclical · Specialty Retail
HK$0.073 (+32.73%) as of
Key statistics
- Market cap
- 231.21M
- EPS (TTM)
- -0.320
- Dividend yield
- 0.00%
- 52-week range
- 0.050 – 0.435
- Beta
- 0.39
- Revenue (TTM)
- 2.27M
- Profit margin
- 0.00%
- Volume
- 175.16M
About Starcoin Group Limited
Starcoin Group Limited, an investment holding company, engages in the trading of beauty products in the People's Republic of China and Hong Kong. It operates in two segments, Trading of Beauty Products, and Research and Development. The company is also involved in the research, development, and commercialization of oral insulin products; and the provision of genetic testing services, as well as securities investment. In addition, it offers healthcare management and bio-industrial products distribution services. The company has a strategic cooperation agreement with Huamei Haibo Biotechnology (Chongqing) Co., Ltd for development in the biotechnology and healthcare sectors. The company was formerly known as Innovative Pharmaceutical Biotech Limited and changed its name to Starcoin Group Limited in August 2025. Starcoin Group Limited was incorporated in 2000 and is based in Central, Hong Kong.
- Sector
- Consumer Cyclical
- Industry
- Specialty Retail
- Headquarters
- Central, Hong Kong
- Employees
- 29
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.